Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Nov;168(11):1195-201.
doi: 10.1176/appi.ajp.2011.10121723. Epub 2011 May 15.

Validating the measurement of real-world functional outcomes: phase I results of the VALERO study

Affiliations
Multicenter Study

Validating the measurement of real-world functional outcomes: phase I results of the VALERO study

Philip D Harvey et al. Am J Psychiatry. 2011 Nov.

Abstract

Objective: Treatment of cognitive impairment has been proposed as an intervention to reduce disability in people with schizophrenia. The Validation of Everyday Real-World Outcomes (VALERO) study was conducted to evaluate functional rating scales and to identify the rating scale or scales most robustly related to performance-based measures of cognition and everyday living skills.

Method: Adults with schizophrenia (N=198) were tested with the neurocognitive measures from the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery, the UCSD Performance-Based Skills Assessment-Brief Version, and the advanced finances subscale of the Everyday Functioning Battery. They and an informant (a friend, relative, clinician, or case manager) also reported their everyday functioning on six rating scales. Best judgment ratings were generated by an interviewer who administered the rating scales to patients and informants.

Results: Statistical analyses developed an ability latent trait that reflected scores on the three performance-based (i.e., ability) measures, and canonical correlation analysis related interviewer ratings to the latent trait. The overall fit of the model with all six rating scales was good. Individual rating scales that did not improve the fit of the model were systematically deleted, and a final model with two rating scales was fitted to the data. A regression analysis found that the Specific Levels of Functioning Assessment was a superior predictor of the three performance-based ability measures.

Conclusions: Systematic assessments of real-world functioning were related to performance on neurocognitive and functional capacity measures. Of the six rating scales evaluated in this study, the Specific Levels of Functioning Assessment was the best. Use of a single rating scale provides an efficient assessment of real-world functioning that accounts for considerable variance in performance-based scores.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Model Fits During Sequential Deletion of Real-world Functioning Scalesa
a RMSEA = root mean square error of approximation b Best fitting model: smallest chi-square value, largest p-value, and smallest RMSEA; the remaining scales were the Life Skills Profile and the Specific Levels of Functioning Assessment.

References

    1. Murray CJL, Lopez AD. Global mortality, disability, and the contributions of risk factors: Global burden of disease study. Lancet. 1997;349:1436–1442. - PubMed
    1. Wiersma D, Wanderling J, Dragomirecka E. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med. 2000;30:1155–1167. - PubMed
    1. Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson L, Heaton RK, Harvey PD. Predicting schizophrenia patients’ real world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry. 2008;63:505–511. - PMC - PubMed
    1. Twamley EW, Doshi RR, Nayak GV, Palmer B. Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry. 2002;159:2013–2020. - PubMed
    1. Harvey PD. Pharmacological cognitive enhancement in schizophrenia. Neuropsychol Rev. 2009;19:324–35. - PubMed

Publication types